The emerging approach of this peptide represents a significant breakthrough in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment